{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:08:02Z","timestamp":1788044882840,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:00:00Z","timestamp":1339459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s10753-012-9488-8","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T11:16:31Z","timestamp":1339413391000},"page":"1706-1714","source":"Crossref","is-referenced-by-count":8,"title":["Celecoxib Enhances the Anti-inflammatory Effects of Farnesylthiosalicylic Acid on T Cells Independent of Prostaglandin E2 Production"],"prefix":"10.1007","volume":"35","author":[{"given":"Adam","family":"Mor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Aizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,12]]},"reference":[{"key":"9488_CR1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/ard.2010.128660","volume":"70","author":"G Burmester","year":"2011","unstructured":"Burmester, G., A. Lanas, L. Biasucci, M. Hermann, S. Lohmander, I. Olivieri, et al. 2011. The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Annals of the Rheumatic Diseases 70: 818\u2013822.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9488_CR2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","volume":"355","author":"N Arber","year":"2006","unstructured":"Arber, N., C.J. Eagle, J. Spicak, I. R\u00e1cz, P. Dite, J. Hajer, et al. 2006. Celecoxib for the prevention of colorectal adenomatous polyps. The New England Journal of Medicine 355: 885\u2013895.","journal-title":"The New England Journal of Medicine"},{"key":"9488_CR3","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/jid.2011.152","volume":"131","author":"A Mor","year":"2011","unstructured":"Mor, A., R. Haklai, O. Ben-Moshe, Y.A. Mekori, and Y. Kloog. 2011. Inhibition of contact sensitivity by farnesylthiosalicylic acid-amide, a potential Rap1 inhibitor. The Journal of Investigative Dermatology 131: 2040\u20132048.","journal-title":"The Journal of Investigative Dermatology"},{"key":"9488_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jneuroim.2010.08.022","volume":"229","author":"E Aizman","year":"2010","unstructured":"Aizman, E., A. Mor, J. Chapman, Y. Assaf, and Y. Kloog. 2010. The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice. Journal of Neuroimmunology 229: 192\u2013203.","journal-title":"Journal of Neuroimmunology"},{"key":"9488_CR5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10753-010-9236-x","volume":"34","author":"A Mor","year":"2011","unstructured":"Mor, A., O. Ben-Moshe, Y.A. Mekori, and Y. Kloog. 2011. Inhibitory effect of farnesylthiosalicylic acid on mediators release by mast cells: preferential inhibition of prostaglandin D2 and tumor necrosis factor-\u03b1 release. Inflammation 34: 314\u2013318.","journal-title":"Inflammation"},{"key":"9488_CR6","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1182\/blood-2005-09-3926","volume":"107","author":"B Hoang","year":"2006","unstructured":"Hoang, B., L. Zhu, Y. Shi, P. Frost, H. Yan, S. Sharma, et al. 2006. Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance. Blood 107: 4484\u20134490.","journal-title":"Blood"},{"key":"9488_CR7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI592","volume":"102","author":"C Capodici","year":"1998","unstructured":"Capodici, C., M.H. Pillinger, G. Han, M.R. Philips, and G. Weissmann. 1998. Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1\/Mek\/Erk via a 5-lipoxygenase-dependent pathway. The Journal of Clinical Investigation 102: 165\u2013175.","journal-title":"The Journal of Clinical Investigation"},{"key":"9488_CR8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2007.00538.x","volume":"218","author":"A Mor","year":"2007","unstructured":"Mor, A., M.L. Dustin, and M.R. Philips. 2007. Small GTPases and LFA-1 reciprocally modulate adhesion and signaling. Immunological Reviews 218: 114\u2013125.","journal-title":"Immunological Reviews"},{"key":"9488_CR9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ncb1592","volume":"9","author":"A Mor","year":"2007","unstructured":"Mor, A., G. Campi, G. Du, Y. Zheng, D.A. Foster, M.L. Dustin, et al. 2007. The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nature Cell Biology 9: 713\u2013719.","journal-title":"Nature Cell Biology"},{"key":"9488_CR10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou, T.C. 2010. Drug combination studies and their synergy quantification using the Chou\u2013Talalay method. Cancer Research 70: 440\u2013446.","journal-title":"Cancer Research"},{"key":"9488_CR11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1158\/1078-0432.CCR-04-1877","volume":"11","author":"MI Patel","year":"2005","unstructured":"Patel, M.I., K. Subbaramaiah, B. Du, M. Chang, P. Yang, R.A. Newman, et al. 2005. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Clinical Cancer Research 11: 1999\u20132007.","journal-title":"Clinical Cancer Research"},{"key":"9488_CR12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1593\/neo.04652","volume":"7","author":"J Du","year":"2005","unstructured":"Du, J., B. Jiang, and J. Barnard. 2005. Differential regulation of cyclooxygenase-2 in nontransformed and ras-transformed intestinal epithelial cells. Neoplasia 7: 761\u2013770.","journal-title":"Neoplasia"},{"key":"9488_CR13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mc.20333","volume":"46","author":"GA Repasky","year":"2007","unstructured":"Repasky, G.A., Y. Zhou, S. Morita, and C.J. Der. 2007. Ras-mediated intestinal epithelial cell transformation requires cyclooxygenase-2-induced prostaglandin E2 signaling. Molecular Carcinogenesis 46: 958\u2013970.","journal-title":"Molecular Carcinogenesis"},{"key":"9488_CR14","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1158\/0008-5472.CAN-07-0970","volume":"67","author":"H Funahashi","year":"2007","unstructured":"Funahashi, H., M. Satake, D. Dawson, N.A. Huynh, H.A. Reber, O.J. Hines, et al. 2007. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. Cancer Research 67: 7068\u20137071.","journal-title":"Cancer Research"},{"key":"9488_CR15","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1073\/pnas.95.24.14540","volume":"95","author":"MH Pillinger","year":"1998","unstructured":"Pillinger, M.H., C. Capodici, P. Rosenthal, N. Kheterpal, S. Hanft, M.R. Philips, et al. 1998. Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion. Proceedings of the National Academy of Sciences of the United States of America 95: 14540\u201314545.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9488_CR16","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1158\/0008-5472.CAN-04-3671","volume":"65","author":"D Wang","year":"2005","unstructured":"Wang, D., F.G. Buchanan, H. Wang, S.K. Dey, and R.N. DuBois. 2005. Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Research 65: 1822\u20131829.","journal-title":"Cancer Research"},{"key":"9488_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jcp.21205","volume":"214","author":"OF Dajani","year":"2008","unstructured":"Dajani, O.F., K. Meisdalen, T.K. Guren, M. Aasrum, I.H. Tveteraas, P. Lilleby, et al. 2008. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes. Journal of Cellular Physiology 214: 371\u2013380.","journal-title":"Journal of Cellular Physiology"},{"key":"9488_CR18","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","volume":"15","author":"S Gr\u00f6sch","year":"2001","unstructured":"Gr\u00f6sch, S., I. Tegeder, E. Niederberger, L. Br\u00e4utigam, and G. Geisslinger. 2001. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. The FASEB Journal 15: 2742\u20132744.","journal-title":"The FASEB Journal"},{"key":"9488_CR19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1096\/fj.02-0947fje","volume":"17","author":"V Jendrossek","year":"2003","unstructured":"Jendrossek, V., R. Handrick, and C. Belka. 2003. Celecoxib activates a novel mitochondrial apoptosis signaling pathway. The FASEB Journal 17: 1547\u20131549.","journal-title":"The FASEB Journal"},{"key":"9488_CR20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/mol.109.057844","volume":"76","author":"LI Brueggemann","year":"2009","unstructured":"Brueggemann, L.I., A.R. Mackie, B.K. Mani, L.L. Cribbs, and K.L. Byron. 2009. Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. Molecular Pharmacology 76: 1053\u20131061.","journal-title":"Molecular Pharmacology"},{"key":"9488_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.163.1.111","volume":"163","author":"MA I\u00f1iguez","year":"1999","unstructured":"I\u00f1iguez, M.A., C. Punz\u00f3n, and M. Fresno. 1999. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. Journal of Immunology 163: 111\u2013119.","journal-title":"Journal of Immunology"},{"key":"9488_CR22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.intimp.2010.07.013","volume":"10","author":"MA I\u00f1iguez","year":"2010","unstructured":"I\u00f1iguez, M.A., C. Punz\u00f3n, C. Cacheiro-Llaguno, M.D. D\u00edaz-Mu\u00f1oz, J. Duque, R. Cuberes, et al. 2010. Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors. International Immunopharmacology 10: 1295\u20131304.","journal-title":"International Immunopharmacology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9488-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-012-9488-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9488-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T08:19:05Z","timestamp":1687508345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-012-9488-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,12]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["9488"],"URL":"https:\/\/doi.org\/10.1007\/s10753-012-9488-8","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,12]]}}}